Mantra Bio

Mantra Bio Overview

  • Founded
  • 2016
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 5

Mantra Bio General Information


Developer of an exosome intelligence platform designed for effective and safe ultra-targeted therapies. The company's platform synthesizes therapeutic exosomes carrying drug payloads such as small molecules or genetic material to target previously undruggable intracellular targets, providing medical practitioners with a drug to combat intractable diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 455 Mission Bay Boulevard South
  • San Francisco, CA 94158
  • United States

Mantra Bio Timeline

Financing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Mantra Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 23-Apr-2018 Completed Startup
2. Accelerator/Incubator 01-Jan-2018 Completed Startup
1. Accelerator/Incubator 26-Jul-2017 Completed Startup

Mantra Bio Executive Team (2)

Name Title Board Seat Contact Info
Alexander Mok Co-Founder & Chief Executive Officer
Catherine Planey Co-Founder & Chief Technology Officer

Mantra Bio Investors (5)

To view Mantra Bio‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
8VC Venture Capital Minority 000 0000 000000 0
BoxGroup Venture Capital Minority 000 0000 000000 0
Nathaniel Turner Angel (individual) Minority 000 0000 000000 0
Springboard Enterprises Accelerator/Incubator 000 0000 000000 0
Illumina Accelerator Accelerator/Incubator 000 0000 000000 0

Ready to get started?

Request a free trial